Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Chronic Pain Treatment Market CAGR Outlook And Future Development
The chronic pain treatment market has demonstrated substantial expansion in recent years. This sector is anticipated to increase from $109.05 billion in 2025 to $119.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Historically, this growth has been fueled by factors such as opioid usage, musculoskeletal disorders, an aging population, the establishment of hospital pain clinics, and advancements in post-surgical pain management.
The chronic pain treatment market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $168.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This projected growth during the forecast period is fueled by factors such as opioid regulation, the development of device-based therapies, the rising prevalence of chronic diseases, increased integration of mental health services, and the expansion of outpatient pain care. Significant developments expected over this period encompass a move towards non-opioid pain treatments, the rise of neuromodulation devices, broadening multidisciplinary pain management approaches, a heightened emphasis on individualized pain care, and the incorporation of psychological support strategies.
Get A Free Sample Report With In-Depth Market Insights:
Chronic Pain Treatment Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of arthritis pain is projected to drive the expansion of the chronic pain treatment market in the future. Arthritis pain describes discomfort, aching, or soreness within the joints, resulting from inflammation or degeneration caused by arthritis. The growing prevalence of arthritis pain is primarily influenced by the aging population, as the natural wear and tear on joints intensifies with age, leading to a higher incidence of arthritis-related conditions. Chronic pain treatment aids arthritis pain by targeting inflammation and nerve sensitivity to lessen discomfort, enhance joint function, and improve the overall quality of life for individuals managing persistent arthritis symptoms. For example, in July 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis pain is a significant factor propelling the growth of the chronic pain treatment market.
Chronic Pain Treatment Market Segment Landscape: Which Areas Lead Development?
The chronic pain treatment market covered in this report is segmented –
1) By Product Type: Drugs, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By Distribution channels: Direct, Indirect
4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications
2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices
Chronic Pain Treatment Market Trends Powering Strategic Industry Growth
Major companies operating in the chronic pain treatment market are prioritizing the development of innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems. This focus is driven by the increasing demand for advanced non-opioid therapies, improved long-term pain management, and enhanced patient quality of life. Closed-loop SCS systems are implantable, rechargeable neurostimulators that continuously detect neural signals and automatically modify electrical stimulation in real time, unlike traditional open-loop SCS devices which deliver predetermined and non-responsive output. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv Neurostimulation System. This device is a compact rechargeable implant that uses sensing electrodes to monitor evoked neural responses and automatically adjust stimulation. It provides full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. Its design aims to deliver more consistent pain relief, better responder outcomes, and improved comfort compared with traditional fixed-output SCS systems.
Chronic Pain Treatment Market Industry Leaders And Competitive Landscape
Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.
View The Full Chronic Pain Treatment Market Report:
Chronic Pain Treatment Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model